KALY – Kali-Extracts Confirms Cannabinoid Testing For $5 Million Hemp Extraction Contract
August 29, 2019 15:24 ET
|
Kali, Inc.
DALLAS, Aug. 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) confirms initiating cannabinoid tests on hemp flowers...
KALY – Kali-Extracts Prepares For First Hemp Harvest And CBD Extraction On Contract Worth Anticipated $5 Million
August 29, 2019 09:00 ET
|
Kali, Inc.
DALLAS, Aug. 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its first cannabinoid tests on hemp...
KALY- Kali-Extracts Analyst Coverage Speculates $0.05 PPS On Biopharmaceutical Cannabis Extract
August 28, 2019 10:14 ET
|
Kali, Inc.
DALLAS, Aug. 28, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a new analyst report from Goldman Small...
KALY- Kali-Extracts Announces New Analyst Report Speculating $0.05 PPS Following Recent Biopharmaceutical Cannabis Extract Updates
August 27, 2019 17:00 ET
|
Kali, Inc.
DALLAS, Aug. 27, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a new analyst report covering the...
KALY – Kali-Extracts Announces Analyst Report Covering Recent Cannabis Biopharmaceutical Developments For Release After Market Today
August 27, 2019 09:00 ET
|
Kali, Inc.
DALLAS, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Aug 27, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the...
KALY – Kali Extracts $15 Million In CBD Extraction Contracts Included In Upcoming Analyst Report
August 26, 2019 09:21 ET
|
Kali, Inc.
DALLAS, Aug. 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today clarified that the analyst report scheduled for...
KALY – Kali Extracts Confirms Analyst Report On Cannabis Extract Biopharmaceutical Strategy Scheduled For Publication Next Week
August 23, 2019 11:45 ET
|
Kali, Inc.
DALLAS, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the publication of an analyst report covering the company’s...
KALY – Kali Extracts Announces New Website For Its RespRx CBD Formulation To Treat Chronic Obstructive Pulmonary Disease Affecting 65 Million Worldwide
August 23, 2019 09:00 ET
|
Kali, Inc.
DALLAS, Aug. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published a new website dedicated to providing...
KALY – Kali-Extracts Confirm Website Launch For RespRx CBD COPD Treatment Formulation Scheduled For Tomorrow
August 22, 2019 13:32 ET
|
Kali, Inc.
DALLAS, Aug. 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled website launch for tomorrow...
KALY - Kali-Extracts Realizes 250% Revenue Growth From New Cannabis Business With Even More Dramatic Growth Anticipated In Second Half Of 2019
August 22, 2019 09:00 ET
|
Kali, Inc.
KALY 1st Six Months 2019 Revenue Is $165,000 Compared To $46,000 Last YearKALY Also Reported $70,000 Operating Net Income 1st Six Months 2019250% Revenue Growth Results From Q4 2018 Cannabis Business...